FGFR1 and head and neck squamous cell carcinoma: Thereafter, a metanalysis involving nine studies delineated that the expression of fibroblast growth factor receptor 1 (FGFR-1) also predicted poor OS (HR, 1.97; 95% CI: 1.49-2.61; p < 0.001) in patients with HNSCC (75).